Oncogene - Table of Contents alert Volume 34 Issue 15

If you are unable to see the message below, click here to view.

Advertisement Validated ChIP antibodies you can TRUST - and try a sample! Partnering with epigenetics experts in the BLUEPRINT epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more and try a sample today. TABLE OF CONTENTS Volume 34, Issue 15 (April 2015) In this issue Reviews Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Don't let your data go to waste... Scientific Data helps researchers make the most of their data, offering publication in a peer reviewed open access journal. We welcome data of all sizes, from all areas of science. What's unique? A new type of article providing detailed descriptions of scientifically valuable datasets, maximising data discoverability and reuse.  Discover what we can do for your data Reviews Top Caspase-2: the reinvented enzyme M Olsson, J Forsberg and B Zhivotovsky Oncogene 2015 34: 1877-1882; advance online publication, June 2, 2014; 10.1038/onc.2014.139 Abstract | Full Text Targeting the oncogenic Met receptor by antibodies and gene therapy E Vigna and P M Comoglio Oncogene 2015 34: 1883-1889; advance online publication, June 2, 2014; 10.1038/onc.2014.142 Abstract | Full Text RACK1, a versatile hub in cancer J-J Li and D Xie Oncogene 2015 34: 1890-1898; advance online publication, June 2, 2014; 10.1038/onc.2014.127 Abstract | Full Text Original Articles Top Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer Q H Miow, T Z Tan, J Ye, J A Lau, T Yokomizo, J-P Thiery and S Mori Oncogene 2015 34: 1899-1907; advance online publication, May 26, 2014; 10.1038/onc.2014.136 Abstract | Full Text miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2 M D Jansson, N D Damas, M Lees, A Jacobsen and A H Lund Oncogene 2015 34: 1908-1918; advance online publication, June 2, 2014; 10.1038/onc.2014.130 Abstract | Full Text Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy D Elias, H Vever, A-V Lænkholm, M F Gjerstorff, C W Yde, A E Lykkesfeldt and H J Ditzel Oncogene 2015 34: 1919-1927; advance online publication, June 2, 2014; 10.1038/onc.2014.138 Abstract | Full Text Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways M V Bais, G B Ozdener, G E Sonenshein and P C Trackman Oncogene 2015 34: 1928-1937; advance online publication, June 2, 2014; 10.1038/onc.2014.147 Abstract | Full Text Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal−/− mice T Zhao, H Du, X Ding, K Walls and C Yan Oncogene 2015 34: 1938-1948; advance online publication, June 2, 2014; 10.1038/onc.2014.143 Abstract | Full Text Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation O Shimozato, M Waraya, K Nakashima, H Souda, N Takiguchi, H Yamamoto, H Takenobu, H Uehara, E Ikeda, S Matsushita, N Kubo, A Nakagawara, T Ozaki and T Kamijo Oncogene 2015 34: 1949-1960; advance online publication, June 2, 2014; 10.1038/onc.2014.141 Abstract | Full Text Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints S V del Rincón, M Widschwendter, D Sun, S Ekholm-Reed, J Tat, L K Teixeira, Z Ellederova, E Grolieres, S I Reed and C Spruck Oncogene 2015 34: 1961-1967; advance online publication, May 26, 2014; 10.1038/onc.2014.137 Abstract | Full Text MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling F Xiao, H Qiu, H Cui, X Ni, J Li, W Liao, L Lu and K Ding Oncogene 2015 34: 1968-1978; advance online publication, June 2, 2014; 10.1038/onc.2014.134 Abstract | Full Text Vimentin regulates lung cancer cell adhesion through a VAV2–Rac1 pathway to control focal adhesion kinase activity L S Havel, E R Kline, A M Salgueiro and A I Marcus Oncogene 2015 34: 1979-1990; advance online publication, May 26, 2014; 10.1038/onc.2014.123 Abstract | Full Text A cadherin switch underlies malignancy in high-grade gliomas I Appolloni, M Barilari, S Caviglia, E Gambini, E Reisoli and P Malatesta Oncogene 2015 34: 1991-2002; advance online publication, May 26, 2014; 10.1038/onc.2014.122 Abstract | Full Text Short Communication Top Mammary glands exhibit molecular laterality and undergo left–right asymmetric ductal epithelial growth in MMTV-cNeu mice* J P Robichaux, R M Hallett, J W Fuseler, J A Hassell and A F Ramsdell Oncogene 2015 34: 2003-2010; advance online publication, June 9, 2014; 10.1038/onc.2014.149 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.